Tipranavir

Aptivus 250 MG Capsulas Blandas

250 mg cápsula blandaSpainAuthorisedAuthorised 1 Nov 2005

In other countries

The same active substances on other registers, the same brand first.

AptivusCanada · 250 MG · Capsule · Boehringer Ingelheim (Canada) LTD LteeSame brand
AptivusEuropean Union · Boehringer Ingelheim International GmbHSame brand
AptivusCroatiaSame brand
AptivusItaly · Capsula molle · Boehringer Ingelheim International GMBHSame brand
Aptivus 250 mg zachte capsules, zachte capsulesNetherlands · Capsule, zacht · Boehringer Ingelheim International GmbHSame brand
Aptivus 100 mg/ml, drankNetherlands · Drank · Boehringer Ingelheim International GmbHSame brand
AptivusUnited States · 250MG · capsule · Boehringer IngelheimSame brand

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Tipranavir

Aptivus 250 MG Capsulas Blandas

250 mg cápsula blandaSpainAuthorisedAuthorised 1 Nov 2005

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

AptivusUnited States · 100MG/ML · solution · Boehringer Ingelheim

ElodiusBrazil · Boehringer Ingelheim do Brasil Química e Farmacêutica Ltda.

Packs

Pack	Code	Status
APTIVUS 250 MG CAPSULAS BLANDAS, 120 cápsulas	652162

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Tipranavir
Strength: 250 mg
Dosage form: cápsula blanda
Route: vía oral
Register: Spain (AEMPS)
Status: Authorised
Status in the register: Autorizado, no comercializado
Authorised: 1 Nov 2005
Registration: 05315001
Marketing authorisation holder: Boehringer Ingelheim International Gmbh
Procedure: EU centralised
Supply: Diagnóstico Hospitalario